Thursday, 27 September 2018 20:42
Clinical Trials of Cuban Lung Cancer Vaccine in the US Were Satisfactory
The Roswell Park Comprehensive Cancer Center announced on Wednesday that the initial results of the first North American clinical study of the CIMAvax-EGF vaccine show that this immunotherapy developed in Cuba is safe, well tolerated and deserves further study.
Published in
Health
Friday, 24 March 2017 17:22
Cuban Vaccine against Lung Cancer Goes to Clinical Trial at Primary Health Care Level
Havana, Cuba.- With nearly 200 patients, a clinical trial of the drug Cimavax EGF against lung cancer in primary health care (PHC) is being developed in Cuba to evaluate other parameters in order to increase the effectiveness of the first vaccine of its type registered in the world.
Published in
Health
